Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,926,556
+$8,194,964 QoQ
Shares Held
599,903
+825.8% QoQ
Ownership
0.397%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#43
of 294 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Longaeva Partners L.P. holds $318,796,543 across 43 Biotechnology names. BHVN ranks #14 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QURE |
uniQure N.V.
|
804,594 | $37,059,599 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
110,261 | $33,191,868 | |
| 3 | INSM |
INSMED Inc
|
201,226 | $21,454,716 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
68,792 | $16,576,808 | |
| 5 | ELVN |
Enliven Therapeutics, Inc.
|
312,560 | $15,862,420 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,279 | $15,040,487 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
187,863 | $13,992,036 | |
| 8 | CTNM |
Contineum Therapeutics, Inc.
|
812,757 | $13,321,087 |
All Filings in BHVN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,926,556 | 599,903 | Shares | Other | 2026-08-14 | |
| 2025-12-31 | $731,592 | 64,800 | Shares | Other | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||